In today’s increasingly competitive and fast-paced marketplace, brands are an important and often overlooked asset for maximizing commercial value for pharmaceutical companies. Strong brands drive price premiums, mitigate competitive marketplace erosion, and encapsulate goodwill and customer loyalty from product launch to post-exclusivity. This presentation focuses on the commercial importance of pharmaceutical brands in the marketplace, particularly in light of rapidly evolving dynamics. It will cover interesting data on pricing, competition, FDA approvals, marketing, loss of exclusivity, and illuminate the potential for brands to help maximize competitive advantage and profitability. We will end with concrete guidance on navigating complex legal processes and implementing strong brand strategies.
Janet Cullum – Partner, Cooley
John Harre – Vice President, Intellectual Property, Intarcia Therapeutics
Karen Won – Special Counsel, Cooley
For additional information, please email Seema Desai.
Event details and registration